Antibiotic Injection Franchise in Ahmedabad

Injection Supplier in Mumbai

Antibiotic Medicine Distributor in Delhi

Ampicillin Injection Manufacturer in Bangalore

Pharma Injection Stockist in Hyderabad
Antibiotic Injection Exporter in Chandigarh

Home/Products /ampicillin-250mg-sulbactam-125mg-injection

Amilinc S 125 Injection

Composition : Ampicillin (250mg) + Sulbactam (125mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 125mg

Price : ₹1/-

Amilinc S 125 Injection contains Ampicillin and Sulbactam, a combination antibiotic used for the treatment of various bacterial infections. It is effective against a wide range of infections including respiratory, urinary tract, skin, and soft tissue infections.

Ampicillin works by inhibiting bacterial cell wall synthesis, while Sulbactam acts as a beta-lactamase inhibitor, enhancing the effectiveness of Ampicillin against resistant bacteria. This combination ensures improved antibacterial activity and better treatment outcomes.

This injection is widely used in hospitals and clinical settings for moderate to severe infections. Its broad-spectrum coverage and reliable efficacy make it a preferred choice among healthcare professionals for infection management.

With increasing demand for effective antibiotic therapies, this product offers strong market potential. Its hospital usage, consistent prescription demand, and wide application range make it a dependable option for business growth in the anti-infective segment.

Read More

About the Product

Amilinc S 125 Injection contains Ampicillin and Sulbactam, a combination antibiotic used for the treatment of various bacterial infections. It is effective against a wide range of infections including respiratory, urinary tract, skin, and soft tissue infections.

Ampicillin works by inhibiting bacterial cell wall synthesis, while Sulbactam acts as a beta-lactamase inhibitor, enhancing the effectiveness of Ampicillin against resistant bacteria. This combination ensures improved antibacterial activity and better treatment outcomes.

This injection is widely used in hospitals and clinical settings for moderate to severe infections. Its broad-spectrum coverage and reliable efficacy make it a preferred choice among healthcare professionals for infection management.

With increasing demand for effective antibiotic therapies, this product offers strong market potential. Its hospital usage, consistent prescription demand, and wide application range make it a dependable option for business growth in the anti-infective segment.

Common side effects may include pain at the injection site, nausea, vomiting, diarrhea, and skin rash. Some patients may experience allergic reactions, such as itching or swelling. Rarely, severe hypersensitivity reactions or liver enzyme elevations may occur.

Amilinc S 125 Injection (Ampicillin 250 mg + Sulbactam 125 mg) is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and gynecological infections. It works by inhibiting bacterial growth and overcoming resistance.

This medication should be administered under the supervision of a healthcare professional. Complete the full course of treatment as prescribed. Inform your doctor if you have a history of penicillin allergy or any other medical condition. Use with caution in patients with kidney or liver impairment.

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children and use as directed after reconstitution.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation